Actuate Therapeutics Reports Positive Biomarker and Machine Learning Data from Phase 2 Elraglusib Trial in First-Line Treatment of Metastatic Pancreatic Cancer at ASCO
Phase 2 highlights robust biomarker identification and survival correlations in first-line metastatic…
AMITY SCHOOL OF FASHION TECHNOLOGY SHOWCASES AT DELHI TIMES FASHION WEEK 2025
DELHI, May 29, 2025 /PRNewswire/ -- Students from Amity School of Fashion…
